Açıklama
Supplementary data from the probiotic-fermented herbal therapeutics review, expanding on specific compound-pathway interactions or clinical evidence summaries not covered in the main figures.
Figure 36
Source Paper
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Cite This Figure
![Figure 36: Supplementary data from the probiotic-fermented herbal therapeutics review, expanding on specific compound-pathway interactions or clinical evidence summaries not covered in the main figures.]() > Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)
<figure> <img src="" alt="Supplementary data from the probiotic-fermented herbal therapeutics review, expanding on specific compound-pathway interactions or clinical evidence summaries not covered in the main figures." /> <figcaption>Figure 36. Supplementary data from the probiotic-fermented herbal therapeutics review, expanding on specific compound-pathway interactions or clinical evidence summaries not covered in the main figures.<br> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption> </figure>